nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP19A1—Betamethasone—psoriatic arthritis	0.216	0.289	CbGbCtD
Melatonin—CYP1B1—Dexamethasone—psoriatic arthritis	0.155	0.208	CbGbCtD
Melatonin—CYP19A1—Dexamethasone—psoriatic arthritis	0.126	0.168	CbGbCtD
Melatonin—SLC22A8—Methotrexate—psoriatic arthritis	0.0687	0.0922	CbGbCtD
Melatonin—CYP1A1—Dexamethasone—psoriatic arthritis	0.0679	0.0911	CbGbCtD
Melatonin—CYP2C19—Prednisone—psoriatic arthritis	0.0527	0.0707	CbGbCtD
Melatonin—CYP2C19—Dexamethasone—psoriatic arthritis	0.0329	0.0441	CbGbCtD
Melatonin—CYP2C9—Dexamethasone—psoriatic arthritis	0.0273	0.0367	CbGbCtD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-C—psoriatic arthritis	0.00618	0.106	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00582	0.1	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.00495	0.085	CbGpPWpGaD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-B—psoriatic arthritis	0.00366	0.0628	CbGpPWpGaD
Melatonin—CALR—ER-Phagosome pathway—HLA-C—psoriatic arthritis	0.00286	0.0491	CbGpPWpGaD
Melatonin—CALR—Antigen processing-Cross presentation—HLA-C—psoriatic arthritis	0.00236	0.0405	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.00232	0.0398	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.00215	0.037	CbGpPWpGaD
Melatonin—CALR—ER-Phagosome pathway—HLA-B—psoriatic arthritis	0.00169	0.029	CbGpPWpGaD
Melatonin—ESR1—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.00148	0.0255	CbGpPWpGaD
Melatonin—CALR—Antigen processing-Cross presentation—HLA-B—psoriatic arthritis	0.0014	0.024	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.00121	0.0207	CbGpPWpGaD
Melatonin—MPO—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.00102	0.0176	CbGpPWpGaD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—HLA-C—psoriatic arthritis	0.000942	0.0162	CbGpPWpGaD
Melatonin—Migraine—Betamethasone—psoriatic arthritis	0.000858	0.00438	CcSEcCtD
Melatonin—Affect lability—Dexamethasone—psoriatic arthritis	0.000858	0.00438	CcSEcCtD
Melatonin—Migraine—Dexamethasone—psoriatic arthritis	0.000858	0.00438	CcSEcCtD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000848	0.0146	CbGpPWpGaD
Melatonin—MPO—Folate Metabolism—CRP—psoriatic arthritis	0.000834	0.0143	CbGpPWpGaD
Melatonin—Irritability—Dexamethasone—psoriatic arthritis	0.000832	0.00424	CcSEcCtD
Melatonin—Irritability—Betamethasone—psoriatic arthritis	0.000832	0.00424	CcSEcCtD
Melatonin—Mood swings—Betamethasone—psoriatic arthritis	0.000825	0.00421	CcSEcCtD
Melatonin—Mood swings—Dexamethasone—psoriatic arthritis	0.000825	0.00421	CcSEcCtD
Melatonin—Weight increased—Prednisolone—psoriatic arthritis	0.000821	0.00419	CcSEcCtD
Melatonin—Dry skin—Betamethasone—psoriatic arthritis	0.000799	0.00407	CcSEcCtD
Melatonin—Dry skin—Dexamethasone—psoriatic arthritis	0.000799	0.00407	CcSEcCtD
Melatonin—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00079	0.00403	CcSEcCtD
Melatonin—Urine output increased—Methotrexate—psoriatic arthritis	0.00079	0.00403	CcSEcCtD
Melatonin—Lethargy—Prednisone—psoriatic arthritis	0.000774	0.00395	CcSEcCtD
Melatonin—Weight increased—Triamcinolone—psoriatic arthritis	0.000755	0.00385	CcSEcCtD
Melatonin—Weight increased—Methylprednisolone—psoriatic arthritis	0.000754	0.00384	CcSEcCtD
Melatonin—Affect lability—Prednisone—psoriatic arthritis	0.000747	0.00381	CcSEcCtD
Melatonin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000738	0.00377	CcSEcCtD
Melatonin—Infestation—Methylprednisolone—psoriatic arthritis	0.000738	0.00377	CcSEcCtD
Melatonin—Irritability—Prednisone—psoriatic arthritis	0.000724	0.00369	CcSEcCtD
Melatonin—Polyuria—Methotrexate—psoriatic arthritis	0.000722	0.00368	CcSEcCtD
Melatonin—Mood swings—Prednisone—psoriatic arthritis	0.000719	0.00367	CcSEcCtD
Melatonin—Dry skin—Prednisone—psoriatic arthritis	0.000696	0.00355	CcSEcCtD
Melatonin—Weight increased—Dexamethasone—psoriatic arthritis	0.000685	0.0035	CcSEcCtD
Melatonin—Weight increased—Betamethasone—psoriatic arthritis	0.000685	0.0035	CcSEcCtD
Melatonin—ESR1—Leptin signaling pathway—REL—psoriatic arthritis	0.000681	0.0117	CbGpPWpGaD
Melatonin—MPO—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000662	0.0114	CbGpPWpGaD
Melatonin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000651	0.00332	CcSEcCtD
Melatonin—Lethargy—Methotrexate—psoriatic arthritis	0.000647	0.0033	CcSEcCtD
Melatonin—Erythema—Prednisolone—psoriatic arthritis	0.000629	0.00321	CcSEcCtD
Melatonin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000619	0.00316	CcSEcCtD
Melatonin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000615	0.00314	CcSEcCtD
Melatonin—Irritability—Methotrexate—psoriatic arthritis	0.000605	0.00309	CcSEcCtD
Melatonin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000601	0.00307	CcSEcCtD
Melatonin—Mood swings—Methotrexate—psoriatic arthritis	0.000601	0.00306	CcSEcCtD
Melatonin—MPO—IL23-mediated signaling events—TNF—psoriatic arthritis	0.0006	0.0103	CbGpPWpGaD
Melatonin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000599	0.00305	CcSEcCtD
Melatonin—Weight increased—Prednisone—psoriatic arthritis	0.000597	0.00304	CcSEcCtD
Melatonin—Vision blurred—Prednisolone—psoriatic arthritis	0.000593	0.00302	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000585	0.00299	CcSEcCtD
Melatonin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000581	0.00296	CcSEcCtD
Melatonin—Erythema—Triamcinolone—psoriatic arthritis	0.000578	0.00295	CcSEcCtD
Melatonin—Erythema—Methylprednisolone—psoriatic arthritis	0.000577	0.00294	CcSEcCtD
Melatonin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000577	0.00294	CcSEcCtD
Melatonin—Angioedema—Prednisolone—psoriatic arthritis	0.000575	0.00293	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—psoriatic arthritis	0.000573	0.00292	CcSEcCtD
Melatonin—Vertigo—Prednisolone—psoriatic arthritis	0.000565	0.00288	CcSEcCtD
Melatonin—Syncope—Prednisolone—psoriatic arthritis	0.000564	0.00288	CcSEcCtD
Melatonin—Eye disorder—Dexamethasone—psoriatic arthritis	0.000563	0.00287	CcSEcCtD
Melatonin—Eye disorder—Betamethasone—psoriatic arthritis	0.000563	0.00287	CcSEcCtD
Melatonin—Back pain—Triamcinolone—psoriatic arthritis	0.000559	0.00285	CcSEcCtD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—HLA-B—psoriatic arthritis	0.000557	0.00957	CbGpPWpGaD
Melatonin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000553	0.00282	CcSEcCtD
Melatonin—CALR—Immune System—MEFV—psoriatic arthritis	0.000553	0.00949	CbGpPWpGaD
Melatonin—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriatic arthritis	0.00055	0.00944	CbGpPWpGaD
Melatonin—Angiopathy—Betamethasone—psoriatic arthritis	0.000547	0.00279	CcSEcCtD
Melatonin—Angiopathy—Dexamethasone—psoriatic arthritis	0.000547	0.00279	CcSEcCtD
Melatonin—Hypertension—Prednisolone—psoriatic arthritis	0.000543	0.00277	CcSEcCtD
Melatonin—Angioedema—Triamcinolone—psoriatic arthritis	0.000528	0.0027	CcSEcCtD
Melatonin—Angioedema—Methylprednisolone—psoriatic arthritis	0.000527	0.00269	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000525	0.00268	CcSEcCtD
Melatonin—Erythema—Betamethasone—psoriatic arthritis	0.000525	0.00268	CcSEcCtD
Melatonin—Erythema—Dexamethasone—psoriatic arthritis	0.000525	0.00268	CcSEcCtD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000522	0.00896	CbGpPWpGaD
Melatonin—Vertigo—Triamcinolone—psoriatic arthritis	0.00052	0.00265	CcSEcCtD
Melatonin—Syncope—Triamcinolone—psoriatic arthritis	0.000519	0.00265	CcSEcCtD
Melatonin—Vertigo—Methylprednisolone—psoriatic arthritis	0.000518	0.00264	CcSEcCtD
Melatonin—Syncope—Methylprednisolone—psoriatic arthritis	0.000517	0.00264	CcSEcCtD
Melatonin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000516	0.00263	CcSEcCtD
Melatonin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000508	0.00259	CcSEcCtD
Melatonin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000507	0.00259	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—REL—psoriatic arthritis	0.000507	0.00871	CbGpPWpGaD
Melatonin—Shock—Prednisolone—psoriatic arthritis	0.000505	0.00258	CcSEcCtD
Melatonin—MTNR1A—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000505	0.00867	CbGpPWpGaD
Melatonin—MTNR1B—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000505	0.00867	CbGpPWpGaD
Melatonin—Hypertension—Triamcinolone—psoriatic arthritis	0.000499	0.00255	CcSEcCtD
Melatonin—Hypertension—Methylprednisolone—psoriatic arthritis	0.000498	0.00254	CcSEcCtD
Melatonin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000491	0.00251	CcSEcCtD
Melatonin—Eye disorder—Prednisone—psoriatic arthritis	0.000491	0.0025	CcSEcCtD
Melatonin—Anxiety—Methylprednisolone—psoriatic arthritis	0.00049	0.0025	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—psoriatic arthritis	0.000489	0.00249	CcSEcCtD
Melatonin—Infestation—Methotrexate—psoriatic arthritis	0.000489	0.00249	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000488	0.00249	CcSEcCtD
Melatonin—Dry mouth—Triamcinolone—psoriatic arthritis	0.000482	0.00246	CcSEcCtD
Melatonin—Angioedema—Dexamethasone—psoriatic arthritis	0.000479	0.00245	CcSEcCtD
Melatonin—Angioedema—Betamethasone—psoriatic arthritis	0.000479	0.00245	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—psoriatic arthritis	0.000476	0.00243	CcSEcCtD
Melatonin—Angiopathy—Prednisone—psoriatic arthritis	0.000476	0.00243	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—psoriatic arthritis	0.000474	0.00242	CcSEcCtD
Melatonin—Vertigo—Betamethasone—psoriatic arthritis	0.000471	0.00241	CcSEcCtD
Melatonin—Vertigo—Dexamethasone—psoriatic arthritis	0.000471	0.00241	CcSEcCtD
Melatonin—Syncope—Betamethasone—psoriatic arthritis	0.000471	0.0024	CcSEcCtD
Melatonin—Syncope—Dexamethasone—psoriatic arthritis	0.000471	0.0024	CcSEcCtD
Melatonin—Infection—Triamcinolone—psoriatic arthritis	0.000469	0.00239	CcSEcCtD
Melatonin—Infection—Methylprednisolone—psoriatic arthritis	0.000468	0.00239	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000466	0.00801	CbGpPWpGaD
Melatonin—Haematuria—Methotrexate—psoriatic arthritis	0.000466	0.00238	CcSEcCtD
Melatonin—Shock—Triamcinolone—psoriatic arthritis	0.000464	0.00237	CcSEcCtD
Melatonin—Insomnia—Prednisolone—psoriatic arthritis	0.000464	0.00237	CcSEcCtD
Melatonin—MPO—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.000464	0.00797	CbGpPWpGaD
Melatonin—Shock—Methylprednisolone—psoriatic arthritis	0.000463	0.00236	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000462	0.00236	CcSEcCtD
Melatonin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000462	0.00236	CcSEcCtD
Melatonin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000461	0.00235	CcSEcCtD
Melatonin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000461	0.00235	CcSEcCtD
Melatonin—Paraesthesia—Prednisolone—psoriatic arthritis	0.000461	0.00235	CcSEcCtD
Melatonin—Mental disorder—Prednisone—psoriatic arthritis	0.00046	0.00235	CcSEcCtD
Melatonin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000457	0.00233	CcSEcCtD
Melatonin—Erythema—Prednisone—psoriatic arthritis	0.000457	0.00233	CcSEcCtD
Melatonin—Malnutrition—Prednisone—psoriatic arthritis	0.000457	0.00233	CcSEcCtD
Melatonin—Hypertension—Betamethasone—psoriatic arthritis	0.000453	0.00231	CcSEcCtD
Melatonin—Hypertension—Dexamethasone—psoriatic arthritis	0.000453	0.00231	CcSEcCtD
Melatonin—Anxiety—Dexamethasone—psoriatic arthritis	0.000445	0.00227	CcSEcCtD
Melatonin—Anxiety—Betamethasone—psoriatic arthritis	0.000445	0.00227	CcSEcCtD
Melatonin—Pain—Prednisolone—psoriatic arthritis	0.000439	0.00224	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000433	0.00221	CcSEcCtD
Melatonin—Vision blurred—Prednisone—psoriatic arthritis	0.000431	0.0022	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00043	0.00219	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00043	0.00219	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000429	0.00219	CcSEcCtD
Melatonin—Insomnia—Triamcinolone—psoriatic arthritis	0.000427	0.00218	CcSEcCtD
Melatonin—Insomnia—Methylprednisolone—psoriatic arthritis	0.000426	0.00217	CcSEcCtD
Melatonin—Infection—Dexamethasone—psoriatic arthritis	0.000425	0.00217	CcSEcCtD
Melatonin—Infection—Betamethasone—psoriatic arthritis	0.000425	0.00217	CcSEcCtD
Melatonin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000424	0.00216	CcSEcCtD
Melatonin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000423	0.00216	CcSEcCtD
Melatonin—Shock—Dexamethasone—psoriatic arthritis	0.000421	0.00215	CcSEcCtD
Melatonin—Shock—Betamethasone—psoriatic arthritis	0.000421	0.00215	CcSEcCtD
Melatonin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00042	0.00214	CcSEcCtD
Melatonin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00042	0.00214	CcSEcCtD
Melatonin—Agitation—Prednisone—psoriatic arthritis	0.00042	0.00214	CcSEcCtD
Melatonin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000419	0.00214	CcSEcCtD
Melatonin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000419	0.00214	CcSEcCtD
Melatonin—Angioedema—Prednisone—psoriatic arthritis	0.000418	0.00213	CcSEcCtD
Melatonin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000415	0.00212	CcSEcCtD
Melatonin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000415	0.00211	CcSEcCtD
Melatonin—Vertigo—Prednisone—psoriatic arthritis	0.000411	0.00209	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—psoriatic arthritis	0.00041	0.00209	CcSEcCtD
Melatonin—Syncope—Prednisone—psoriatic arthritis	0.00041	0.00209	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000407	0.00208	CcSEcCtD
Melatonin—Fatigue—Triamcinolone—psoriatic arthritis	0.000407	0.00208	CcSEcCtD
Melatonin—Fatigue—Methylprednisolone—psoriatic arthritis	0.000406	0.00207	CcSEcCtD
Melatonin—Pain—Triamcinolone—psoriatic arthritis	0.000404	0.00206	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—psoriatic arthritis	0.000402	0.00205	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—psoriatic arthritis	0.000398	0.00203	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—psoriatic arthritis	0.000396	0.00202	CcSEcCtD
Melatonin—Hypertension—Prednisone—psoriatic arthritis	0.000395	0.00201	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00039	0.00199	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00039	0.00199	CcSEcCtD
Melatonin—Arthralgia—Prednisone—psoriatic arthritis	0.000389	0.00198	CcSEcCtD
Melatonin—Anxiety—Prednisone—psoriatic arthritis	0.000388	0.00198	CcSEcCtD
Melatonin—Insomnia—Betamethasone—psoriatic arthritis	0.000387	0.00198	CcSEcCtD
Melatonin—Insomnia—Dexamethasone—psoriatic arthritis	0.000387	0.00198	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000386	0.00197	CcSEcCtD
Melatonin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000385	0.00196	CcSEcCtD
Melatonin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000385	0.00196	CcSEcCtD
Melatonin—Paraesthesia—Betamethasone—psoriatic arthritis	0.000385	0.00196	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—psoriatic arthritis	0.000384	0.00196	CcSEcCtD
Melatonin—Erythema—Methotrexate—psoriatic arthritis	0.000382	0.00195	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—psoriatic arthritis	0.000382	0.00195	CcSEcCtD
Melatonin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000378	0.00193	CcSEcCtD
Melatonin—MPO—Folate Metabolism—TNF—psoriatic arthritis	0.000377	0.00648	CbGpPWpGaD
Melatonin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000377	0.00192	CcSEcCtD
Melatonin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000377	0.00192	CcSEcCtD
Melatonin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000372	0.0019	CcSEcCtD
Melatonin—Infection—Prednisone—psoriatic arthritis	0.000371	0.00189	CcSEcCtD
Melatonin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00037	0.00189	CcSEcCtD
Melatonin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00037	0.00189	CcSEcCtD
Melatonin—Back pain—Methotrexate—psoriatic arthritis	0.000369	0.00188	CcSEcCtD
Melatonin—Fatigue—Dexamethasone—psoriatic arthritis	0.000369	0.00188	CcSEcCtD
Melatonin—Fatigue—Betamethasone—psoriatic arthritis	0.000369	0.00188	CcSEcCtD
Melatonin—Shock—Prednisone—psoriatic arthritis	0.000367	0.00187	CcSEcCtD
Melatonin—Pain—Betamethasone—psoriatic arthritis	0.000366	0.00187	CcSEcCtD
Melatonin—Pain—Dexamethasone—psoriatic arthritis	0.000366	0.00187	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000366	0.00187	CcSEcCtD
Melatonin—Skin disorder—Prednisone—psoriatic arthritis	0.000362	0.00185	CcSEcCtD
Melatonin—ESR1—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000362	0.00622	CbGpPWpGaD
Melatonin—Vision blurred—Methotrexate—psoriatic arthritis	0.00036	0.00184	CcSEcCtD
Melatonin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00035	0.00179	CcSEcCtD
Melatonin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00035	0.00179	CcSEcCtD
Melatonin—CALR—Metabolism of proteins—ACE—psoriatic arthritis	0.00035	0.006	CbGpPWpGaD
Melatonin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000348	0.00177	CcSEcCtD
Melatonin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000347	0.00177	CcSEcCtD
Melatonin—Vertigo—Methotrexate—psoriatic arthritis	0.000343	0.00175	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—psoriatic arthritis	0.000342	0.00174	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00034	0.00173	CcSEcCtD
Melatonin—Dizziness—Prednisolone—psoriatic arthritis	0.000339	0.00173	CcSEcCtD
Melatonin—Asthenia—Triamcinolone—psoriatic arthritis	0.000339	0.00173	CcSEcCtD
Melatonin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000339	0.00173	CcSEcCtD
Melatonin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000339	0.00173	CcSEcCtD
Melatonin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000338	0.00172	CcSEcCtD
Melatonin—Insomnia—Prednisone—psoriatic arthritis	0.000337	0.00172	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—psoriatic arthritis	0.000335	0.00171	CcSEcCtD
Melatonin—Pruritus—Triamcinolone—psoriatic arthritis	0.000334	0.0017	CcSEcCtD
Melatonin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000333	0.0017	CcSEcCtD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000333	0.00572	CbGpPWpGaD
Melatonin—Dyspepsia—Prednisone—psoriatic arthritis	0.000328	0.00167	CcSEcCtD
Melatonin—Chest pain—Methotrexate—psoriatic arthritis	0.000325	0.00166	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—psoriatic arthritis	0.000325	0.00166	CcSEcCtD
Melatonin—Rash—Prednisolone—psoriatic arthritis	0.000324	0.00165	CcSEcCtD
Melatonin—Dermatitis—Prednisolone—psoriatic arthritis	0.000323	0.00165	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000323	0.00165	CcSEcCtD
Melatonin—Fatigue—Prednisone—psoriatic arthritis	0.000322	0.00164	CcSEcCtD
Melatonin—Headache—Prednisolone—psoriatic arthritis	0.000322	0.00164	CcSEcCtD
Melatonin—Dizziness—Triamcinolone—psoriatic arthritis	0.000312	0.00159	CcSEcCtD
Melatonin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000311	0.00159	CcSEcCtD
Melatonin—Infection—Methotrexate—psoriatic arthritis	0.00031	0.00158	CcSEcCtD
Melatonin—CALR—Immune System—REL—psoriatic arthritis	0.000307	0.00528	CbGpPWpGaD
Melatonin—Asthenia—Betamethasone—psoriatic arthritis	0.000307	0.00157	CcSEcCtD
Melatonin—Asthenia—Dexamethasone—psoriatic arthritis	0.000307	0.00157	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000306	0.00156	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000305	0.00156	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000305	0.00156	CcSEcCtD
Melatonin—Nausea—Prednisolone—psoriatic arthritis	0.000305	0.00156	CcSEcCtD
Melatonin—Pruritus—Betamethasone—psoriatic arthritis	0.000303	0.00155	CcSEcCtD
Melatonin—Pruritus—Dexamethasone—psoriatic arthritis	0.000303	0.00155	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—psoriatic arthritis	0.000303	0.00154	CcSEcCtD
Melatonin—Vomiting—Triamcinolone—psoriatic arthritis	0.0003	0.00153	CcSEcCtD
Melatonin—MPO—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.0003	0.00515	CbGpPWpGaD
Melatonin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000299	0.00153	CcSEcCtD
Melatonin—Rash—Triamcinolone—psoriatic arthritis	0.000298	0.00152	CcSEcCtD
Melatonin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000297	0.00152	CcSEcCtD
Melatonin—Rash—Methylprednisolone—psoriatic arthritis	0.000297	0.00151	CcSEcCtD
Melatonin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000297	0.00151	CcSEcCtD
Melatonin—Headache—Triamcinolone—psoriatic arthritis	0.000296	0.00151	CcSEcCtD
Melatonin—Headache—Methylprednisolone—psoriatic arthritis	0.000295	0.00151	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—psoriatic arthritis	0.000295	0.0015	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000284	0.00145	CcSEcCtD
Melatonin—Dizziness—Dexamethasone—psoriatic arthritis	0.000283	0.00144	CcSEcCtD
Melatonin—Dizziness—Betamethasone—psoriatic arthritis	0.000283	0.00144	CcSEcCtD
Melatonin—CALR—Immune System—HLA-C—psoriatic arthritis	0.000283	0.00486	CbGpPWpGaD
Melatonin—Insomnia—Methotrexate—psoriatic arthritis	0.000282	0.00144	CcSEcCtD
Melatonin—Nausea—Triamcinolone—psoriatic arthritis	0.00028	0.00143	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—psoriatic arthritis	0.00028	0.00143	CcSEcCtD
Melatonin—Nausea—Methylprednisolone—psoriatic arthritis	0.00028	0.00143	CcSEcCtD
Melatonin—Somnolence—Methotrexate—psoriatic arthritis	0.000277	0.00141	CcSEcCtD
Melatonin—CALM3—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.000276	0.00474	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000276	0.00474	CbGpPWpGaD
Melatonin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000275	0.0014	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000274	0.0014	CcSEcCtD
Melatonin—Vomiting—Dexamethasone—psoriatic arthritis	0.000272	0.00139	CcSEcCtD
Melatonin—Vomiting—Betamethasone—psoriatic arthritis	0.000272	0.00139	CcSEcCtD
Melatonin—Rash—Betamethasone—psoriatic arthritis	0.00027	0.00138	CcSEcCtD
Melatonin—Rash—Dexamethasone—psoriatic arthritis	0.00027	0.00138	CcSEcCtD
Melatonin—Dermatitis—Betamethasone—psoriatic arthritis	0.00027	0.00138	CcSEcCtD
Melatonin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00027	0.00138	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000269	0.00137	CcSEcCtD
Melatonin—Fatigue—Methotrexate—psoriatic arthritis	0.000269	0.00137	CcSEcCtD
Melatonin—Headache—Dexamethasone—psoriatic arthritis	0.000268	0.00137	CcSEcCtD
Melatonin—Headache—Betamethasone—psoriatic arthritis	0.000268	0.00137	CcSEcCtD
Melatonin—Asthenia—Prednisone—psoriatic arthritis	0.000268	0.00137	CcSEcCtD
Melatonin—CALM1—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.000267	0.00459	CbGpPWpGaD
Melatonin—CALM2—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.000267	0.00459	CbGpPWpGaD
Melatonin—Pain—Methotrexate—psoriatic arthritis	0.000267	0.00136	CcSEcCtD
Melatonin—Pruritus—Prednisone—psoriatic arthritis	0.000264	0.00135	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000255	0.0013	CcSEcCtD
Melatonin—Nausea—Betamethasone—psoriatic arthritis	0.000254	0.0013	CcSEcCtD
Melatonin—Nausea—Dexamethasone—psoriatic arthritis	0.000254	0.0013	CcSEcCtD
Melatonin—Dizziness—Prednisone—psoriatic arthritis	0.000247	0.00126	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000246	0.00126	CcSEcCtD
Melatonin—Vomiting—Prednisone—psoriatic arthritis	0.000237	0.00121	CcSEcCtD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000236	0.00405	CbGpPWpGaD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000236	0.00405	CbGpPWpGaD
Melatonin—Rash—Prednisone—psoriatic arthritis	0.000235	0.0012	CcSEcCtD
Melatonin—Dermatitis—Prednisone—psoriatic arthritis	0.000235	0.0012	CcSEcCtD
Melatonin—Headache—Prednisone—psoriatic arthritis	0.000234	0.00119	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000234	0.00401	CbGpPWpGaD
Melatonin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00023	0.00117	CcSEcCtD
Melatonin—Asthenia—Methotrexate—psoriatic arthritis	0.000224	0.00114	CcSEcCtD
Melatonin—Nausea—Prednisone—psoriatic arthritis	0.000222	0.00113	CcSEcCtD
Melatonin—CALM3—B Cell Activation—REL—psoriatic arthritis	0.000221	0.0038	CbGpPWpGaD
Melatonin—Pruritus—Methotrexate—psoriatic arthritis	0.000221	0.00112	CcSEcCtD
Melatonin—CALM3—DAP12 interactions—HLA-C—psoriatic arthritis	0.00022	0.00378	CbGpPWpGaD
Melatonin—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000219	0.00377	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—REL—psoriatic arthritis	0.000214	0.00368	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—REL—psoriatic arthritis	0.000214	0.00368	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—HLA-C—psoriatic arthritis	0.000213	0.00366	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—HLA-C—psoriatic arthritis	0.000213	0.00366	CbGpPWpGaD
Melatonin—CALR—Immune System—NOD2—psoriatic arthritis	0.000208	0.00357	CbGpPWpGaD
Melatonin—Dizziness—Methotrexate—psoriatic arthritis	0.000206	0.00105	CcSEcCtD
Melatonin—Vomiting—Methotrexate—psoriatic arthritis	0.000198	0.00101	CcSEcCtD
Melatonin—Rash—Methotrexate—psoriatic arthritis	0.000197	0.001	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—psoriatic arthritis	0.000196	0.001	CcSEcCtD
Melatonin—Headache—Methotrexate—psoriatic arthritis	0.000195	0.000996	CcSEcCtD
Melatonin—Nausea—Methotrexate—psoriatic arthritis	0.000185	0.000944	CcSEcCtD
Melatonin—CALR—Immune System—HLA-B—psoriatic arthritis	0.000167	0.00287	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—MEFV—psoriatic arthritis	0.000167	0.00287	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—MEFV—psoriatic arthritis	0.000162	0.00278	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—MEFV—psoriatic arthritis	0.000162	0.00278	CbGpPWpGaD
Melatonin—CALR—Immune System—CRP—psoriatic arthritis	0.000148	0.00254	CbGpPWpGaD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000145	0.00249	CbGpPWpGaD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000145	0.00249	CbGpPWpGaD
Melatonin—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.000143	0.00246	CbGpPWpGaD
Melatonin—CALR—Immune System—HLA-DRB1—psoriatic arthritis	0.000142	0.00243	CbGpPWpGaD
Melatonin—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.000139	0.00238	CbGpPWpGaD
Melatonin—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.000139	0.00238	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—HLA-B—psoriatic arthritis	0.00013	0.00224	CbGpPWpGaD
Melatonin—CALM2—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000128	0.0022	CbGpPWpGaD
Melatonin—CALM1—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000128	0.0022	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—HLA-B—psoriatic arthritis	0.000126	0.00216	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—HLA-B—psoriatic arthritis	0.000126	0.00216	CbGpPWpGaD
Melatonin—CALR—Disease—NOS2—psoriatic arthritis	0.000125	0.00214	CbGpPWpGaD
Melatonin—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.000115	0.00197	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.000111	0.00191	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.000111	0.00191	CbGpPWpGaD
Melatonin—CALM3—Alzheimers Disease—TNF—psoriatic arthritis	9.93e-05	0.00171	CbGpPWpGaD
Melatonin—CALM3—Immune System—MEFV—psoriatic arthritis	9.73e-05	0.00167	CbGpPWpGaD
Melatonin—CALM1—Alzheimers Disease—TNF—psoriatic arthritis	9.61e-05	0.00165	CbGpPWpGaD
Melatonin—CALM2—Alzheimers Disease—TNF—psoriatic arthritis	9.61e-05	0.00165	CbGpPWpGaD
Melatonin—CALM2—Immune System—MEFV—psoriatic arthritis	9.41e-05	0.00162	CbGpPWpGaD
Melatonin—CALM1—Immune System—MEFV—psoriatic arthritis	9.41e-05	0.00162	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	9.26e-05	0.00159	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	9.26e-05	0.00159	CbGpPWpGaD
Melatonin—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	9.15e-05	0.00157	CbGpPWpGaD
Melatonin—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	9.15e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—REL—psoriatic arthritis	8.92e-05	0.00153	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—REL—psoriatic arthritis	8.63e-05	0.00148	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—REL—psoriatic arthritis	8.63e-05	0.00148	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HLA-C—psoriatic arthritis	8.55e-05	0.00147	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HLA-C—psoriatic arthritis	8.27e-05	0.00142	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HLA-C—psoriatic arthritis	8.27e-05	0.00142	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-C—psoriatic arthritis	8.21e-05	0.00141	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-C—psoriatic arthritis	7.95e-05	0.00136	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-C—psoriatic arthritis	7.95e-05	0.00136	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	7.02e-05	0.00121	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NOD2—psoriatic arthritis	6.29e-05	0.00108	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NOD2—psoriatic arthritis	6.08e-05	0.00105	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NOD2—psoriatic arthritis	6.08e-05	0.00105	CbGpPWpGaD
Melatonin—CALM3—Immune System—REL—psoriatic arthritis	5.41e-05	0.00093	CbGpPWpGaD
Melatonin—CALM1—Immune System—REL—psoriatic arthritis	5.24e-05	0.000899	CbGpPWpGaD
Melatonin—CALM2—Immune System—REL—psoriatic arthritis	5.24e-05	0.000899	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HLA-B—psoriatic arthritis	5.06e-05	0.000869	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-C—psoriatic arthritis	4.98e-05	0.000856	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HLA-B—psoriatic arthritis	4.89e-05	0.00084	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HLA-B—psoriatic arthritis	4.89e-05	0.00084	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-B—psoriatic arthritis	4.86e-05	0.000834	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-C—psoriatic arthritis	4.82e-05	0.000828	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-C—psoriatic arthritis	4.82e-05	0.000828	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-B—psoriatic arthritis	4.7e-05	0.000807	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-B—psoriatic arthritis	4.7e-05	0.000807	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—NOS2—psoriatic arthritis	4.53e-05	0.000778	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CRP—psoriatic arthritis	4.47e-05	0.000768	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—NOS2—psoriatic arthritis	4.38e-05	0.000752	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—NOS2—psoriatic arthritis	4.38e-05	0.000752	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CRP—psoriatic arthritis	4.32e-05	0.000743	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CRP—psoriatic arthritis	4.32e-05	0.000743	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.11e-05	0.000706	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	3.98e-05	0.000683	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	3.98e-05	0.000683	CbGpPWpGaD
Melatonin—CALM3—Immune System—NOD2—psoriatic arthritis	3.66e-05	0.000629	CbGpPWpGaD
Melatonin—CALM2—Immune System—NOD2—psoriatic arthritis	3.54e-05	0.000609	CbGpPWpGaD
Melatonin—CALM1—Immune System—NOD2—psoriatic arthritis	3.54e-05	0.000609	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-B—psoriatic arthritis	2.95e-05	0.000506	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-B—psoriatic arthritis	2.85e-05	0.000489	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-B—psoriatic arthritis	2.85e-05	0.000489	CbGpPWpGaD
Melatonin—CALM3—Immune System—CRP—psoriatic arthritis	2.6e-05	0.000447	CbGpPWpGaD
Melatonin—CALM1—Immune System—CRP—psoriatic arthritis	2.52e-05	0.000433	CbGpPWpGaD
Melatonin—CALM2—Immune System—CRP—psoriatic arthritis	2.52e-05	0.000433	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-DRB1—psoriatic arthritis	2.49e-05	0.000428	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-DRB1—psoriatic arthritis	2.41e-05	0.000414	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-DRB1—psoriatic arthritis	2.41e-05	0.000414	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS2—psoriatic arthritis	2.19e-05	0.000377	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS2—psoriatic arthritis	2.12e-05	0.000364	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS2—psoriatic arthritis	2.12e-05	0.000364	CbGpPWpGaD
